• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单细胞分析揭示恶性细胞重塑细胞景观并促进结外 NK/T 细胞淋巴瘤的免疫抑制微环境。

Single-Cell Analysis Reveals Malignant Cells Reshape the Cellular Landscape and Foster an Immunosuppressive Microenvironment of Extranodal NK/T-Cell Lymphoma.

机构信息

State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.

Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China.

出版信息

Adv Sci (Weinh). 2023 Dec;10(36):e2303913. doi: 10.1002/advs.202303913. Epub 2023 Nov 10.

DOI:10.1002/advs.202303913
PMID:37949673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10754138/
Abstract

Extranodal natural killer/T-cell lymphoma (NKTCL) is an aggressive type of lymphoma associated with Epstein-Barr virus (EBV) and characterized by heterogeneous tumor behaviors. To better understand the origins of the heterogeneity, this study utilizes single-cell RNA sequencing (scRNA-seq) analysis to profile the tumor microenvironment (TME) of NKTCL at the single-cell level. Together with in vitro and in vivo models, the study identifies a subset of LMP1 malignant NK cells contributing to the tumorigenesis and development of heterogeneous malignant cells in NKTCL. Furthermore, malignant NK cells interact with various immunocytes via chemokines and their receptors, secrete substantial DPP4 that impairs the chemotaxis of immunocytes and regulates their infiltration. They also exhibit an immunosuppressive effect on T cells, which is further boosted by LMP1. Moreover, high transcription of EBV-encoded genes and low infiltration of tumor-associated macrophages (TAMs) are favorable prognostic indicators for NKTCL in multiple patient cohorts. This study for the first time deciphers the heterogeneous composition of NKTCL TME at single-cell resolution, highlighting the crucial role of malignant NK cells with EBV-encoded LMP1 in reshaping the cellular landscape and fostering an immunosuppressive microenvironment. These findings provide insights into understanding the pathogenic mechanisms of NKTCL and developing novel therapeutic strategies against NKTCL.

摘要

结外自然杀伤/T 细胞淋巴瘤(NKTCL)是一种侵袭性淋巴瘤,与 EBV 相关,其肿瘤行为具有异质性。为了更好地理解这种异质性的起源,本研究利用单细胞 RNA 测序(scRNA-seq)分析,在单细胞水平上对 NKTCL 的肿瘤微环境(TME)进行了描绘。通过体外和体内模型,该研究鉴定出 LMP1 恶性 NK 细胞亚群有助于 NKTCL 中肿瘤发生和异质恶性细胞的发展。此外,恶性 NK 细胞通过趋化因子及其受体与各种免疫细胞相互作用,分泌大量 DPP4,损害免疫细胞的趋化性并调节其浸润。它们还对 T 细胞表现出免疫抑制作用,LMP1 进一步增强了这种作用。此外,在多个患者队列中,EBV 编码基因的高转录和肿瘤相关巨噬细胞(TAMs)的低浸润是 NKTCL 的有利预后指标。本研究首次在单细胞分辨率上解析了 NKTCL TME 的异质性组成,突出了 EBV 编码 LMP1 的恶性 NK 细胞在重塑细胞景观和促进免疫抑制微环境方面的关键作用。这些发现为理解 NKTCL 的发病机制和开发针对 NKTCL 的新治疗策略提供了思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a26/10754138/9a3decb5c231/ADVS-10-2303913-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a26/10754138/ee23a28d9b48/ADVS-10-2303913-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a26/10754138/e7c1ca9f17da/ADVS-10-2303913-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a26/10754138/db308cc63bc1/ADVS-10-2303913-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a26/10754138/8255a394755d/ADVS-10-2303913-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a26/10754138/933604961fa8/ADVS-10-2303913-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a26/10754138/9661e5a122af/ADVS-10-2303913-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a26/10754138/9a3decb5c231/ADVS-10-2303913-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a26/10754138/ee23a28d9b48/ADVS-10-2303913-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a26/10754138/e7c1ca9f17da/ADVS-10-2303913-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a26/10754138/db308cc63bc1/ADVS-10-2303913-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a26/10754138/8255a394755d/ADVS-10-2303913-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a26/10754138/933604961fa8/ADVS-10-2303913-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a26/10754138/9661e5a122af/ADVS-10-2303913-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a26/10754138/9a3decb5c231/ADVS-10-2303913-g006.jpg

相似文献

1
Single-Cell Analysis Reveals Malignant Cells Reshape the Cellular Landscape and Foster an Immunosuppressive Microenvironment of Extranodal NK/T-Cell Lymphoma.单细胞分析揭示恶性细胞重塑细胞景观并促进结外 NK/T 细胞淋巴瘤的免疫抑制微环境。
Adv Sci (Weinh). 2023 Dec;10(36):e2303913. doi: 10.1002/advs.202303913. Epub 2023 Nov 10.
2
Genome-Wide Analysis of Epstein-Barr Virus Isolated from Extranodal NK/T-Cell Lymphoma, Nasal Type.从结外 NK/T 细胞淋巴瘤,鼻型中分离的 Epstein-Barr 病毒的全基因组分析。
Oncologist. 2019 Sep;24(9):e905-e913. doi: 10.1634/theoncologist.2017-0588. Epub 2019 Apr 2.
3
Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma.结外自然杀伤/T 细胞淋巴瘤中 EBV 的基因组和转录组图谱。
Leukemia. 2019 Jun;33(6):1451-1462. doi: 10.1038/s41375-018-0324-5. Epub 2018 Dec 13.
4
Analysis of latent T-cell epitopes in Epstein-Barr virus isolated from extranodal nasal-type natural killer/T-cell lymphoma in Taiwanese population.分析从台湾人结外鼻型自然杀伤/T 细胞淋巴瘤分离的 Epstein-Barr 病毒中的潜伏 T 细胞表位。
Exp Mol Pathol. 2021 Feb;118:104577. doi: 10.1016/j.yexmp.2020.104577. Epub 2020 Nov 23.
5
PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma.程序性死亡配体1(PD-L1)由EB病毒驱动的潜伏膜蛋白1(LMP1)通过核因子κB(NF-κB)途径上调,并与自然杀伤/T细胞淋巴瘤的不良预后相关。
J Hematol Oncol. 2016 Oct 13;9(1):109. doi: 10.1186/s13045-016-0341-7.
6
T-cell dysfunction in natural killer/T-cell lymphoma.自然杀伤/T 细胞淋巴瘤中的 T 细胞功能障碍。
Oncoimmunology. 2023 May 24;12(1):2212532. doi: 10.1080/2162402X.2023.2212532. eCollection 2023.
7
Characterization of the humoral immune response to the EBV proteome in extranodal NK/T-cell lymphoma.描述结外 NK/T 细胞淋巴瘤中针对 EBV 蛋白质组的体液免疫反应。
Sci Rep. 2021 Dec 8;11(1):23664. doi: 10.1038/s41598-021-02788-w.
8
LMP1 enhances aerobic glycolysis in natural killer/T cell lymphoma.LMP1 增强自然杀伤/T 细胞淋巴瘤的有氧糖酵解。
Cell Death Dis. 2024 Aug 20;15(8):604. doi: 10.1038/s41419-024-06999-7.
9
Evaluation of the role of Epstein-Barr virus in cases of nodal or extranodal T- and NK-cell lymphoma using eber in situ hybridization.使用爱泼斯坦-巴尔病毒编码的小RNA原位杂交评估爱泼斯坦-巴尔病毒在淋巴结或结外T细胞和NK细胞淋巴瘤病例中的作用。
Pol J Pathol. 2015 Jun;66(2):161-9. doi: 10.5114/pjp.2015.53013.
10
Extranodal NK/T-cell lymphoma: toward the identification of clinical molecular targets.结外NK/T细胞淋巴瘤:迈向临床分子靶点的鉴定
J Biomed Biotechnol. 2011;2011:790871. doi: 10.1155/2011/790871. Epub 2011 Apr 20.

引用本文的文献

1
Cutaneous extranodal NK/T cell lymphoma: heterogeneity of spatial transcriptomic profiling according to primary tumor site.皮肤结外NK/T细胞淋巴瘤:根据原发肿瘤部位的空间转录组分析的异质性
Transl Oncol. 2025 Aug 15;61:102503. doi: 10.1016/j.tranon.2025.102503.
2
Biomarkers of pediatric Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis through single-cell transcriptomics.通过单细胞转录组学研究儿童 Epstein-Barr 病毒相关噬血细胞性淋巴组织细胞增生症的生物标志物
Nat Commun. 2025 Jul 25;16(1):6888. doi: 10.1038/s41467-025-62090-5.
3
Baseline total lesion glycolysis identifies high-risk patients with immunosuppressive signatures in early-stage natural killer/T-cell lymphoma.

本文引用的文献

1
CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma.针对 CD38 和 LMP1 的 CAR-T 细胞对 NK/T 细胞淋巴瘤表现出强大的抗肿瘤活性。
BMC Med. 2023 Aug 30;21(1):330. doi: 10.1186/s12916-023-03040-0.
2
A pan-cancer single-cell panorama of human natural killer cells.人类自然杀伤细胞的泛癌症单细胞全景图。
Cell. 2023 Sep 14;186(19):4235-4251.e20. doi: 10.1016/j.cell.2023.07.034. Epub 2023 Aug 21.
3
Preclinical study of LMP1-RNAi-based anti-tumor therapy in EBV-positive nasopharyngeal carcinoma.
基线总病变糖酵解可识别早期自然杀伤/T细胞淋巴瘤中具有免疫抑制特征的高危患者。
Oncologist. 2025 Jun 4;30(6). doi: 10.1093/oncolo/oyaf164.
4
Viral oncogenesis in cancer: from mechanisms to therapeutics.癌症中的病毒致癌作用:从机制到治疗
Signal Transduct Target Ther. 2025 May 12;10(1):151. doi: 10.1038/s41392-025-02197-9.
5
Efficacy and safety of PD-1/PD-L1 inhibitors for natural killer/T-cell lymphoma: a single-arm meta-analysis.PD-1/PD-L1抑制剂治疗自然杀伤/T细胞淋巴瘤的疗效与安全性:一项单臂荟萃分析。
BMC Cancer. 2025 Mar 3;25(1):385. doi: 10.1186/s12885-025-13812-x.
6
Whole-exome sequencing association study reveals genetic effects on tumor microenvironment components in nasopharyngeal carcinoma.全外显子测序关联研究揭示了对鼻咽癌肿瘤微环境成分的遗传影响。
J Clin Invest. 2025 Jan 2;135(1):e182768. doi: 10.1172/JCI182768.
7
Right ventricular volume overload reboots cardiomyocyte proliferation via immune responses.右心室容量超负荷通过免疫反应重新启动心肌细胞增殖。
J Transl Med. 2024 Nov 28;22(1):1075. doi: 10.1186/s12967-024-05839-8.
8
Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma.单细胞和空间转录组分析揭示了与鼻咽癌肿瘤进展和免疫治疗反应相关的三级淋巴结构。
Nat Commun. 2024 Sep 4;15(1):7713. doi: 10.1038/s41467-024-52153-4.
9
LMP1 enhances aerobic glycolysis in natural killer/T cell lymphoma.LMP1 增强自然杀伤/T 细胞淋巴瘤的有氧糖酵解。
Cell Death Dis. 2024 Aug 20;15(8):604. doi: 10.1038/s41419-024-06999-7.
10
Deciphering the interplay of HPV infection, MHC-II expression, and CXCL13 CD4 T cell activation in oropharyngeal cancer: implications for immunotherapy.解析 HPV 感染、MHC-II 表达和 CXCL13 CD4 T 细胞激活在口咽癌中的相互作用:对免疫治疗的影响。
Cancer Immunol Immunother. 2024 Aug 6;73(10):206. doi: 10.1007/s00262-024-03789-0.
基于 LMP1-RNAi 的抗肿瘤治疗在 EBV 阳性鼻咽癌的临床前研究。
Braz J Med Biol Res. 2023 Jul 21;56:e12638. doi: 10.1590/1414-431X2023e12638. eCollection 2023.
4
Epstein-Barr virus: Biology and clinical disease.爱泼斯坦-巴尔病毒:生物学与临床疾病。
Cell. 2022 Sep 29;185(20):3652-3670. doi: 10.1016/j.cell.2022.08.026. Epub 2022 Sep 15.
5
Identification and Targeting of the Developmental Blockade in Extranodal Natural Killer/T-cell Lymphoma.识别和靶向结外自然杀伤/T 细胞淋巴瘤的发育阻断。
Blood Cancer Discov. 2022 Mar 1;3(2):154-169. doi: 10.1158/2643-3230.BCD-21-0098.
6
Atlas of clinically distinct cell states and ecosystems across human solid tumors.人类实体瘤中具有临床显著差异的细胞状态和生态系统图谱
Cell. 2021 Oct 14;184(21):5482-5496.e28. doi: 10.1016/j.cell.2021.09.014. Epub 2021 Sep 30.
7
Tumour heterogeneity and intercellular networks of nasopharyngeal carcinoma at single cell resolution.单细胞分辨率解析的鼻咽癌肿瘤异质性和细胞间网络。
Nat Commun. 2021 Feb 2;12(1):741. doi: 10.1038/s41467-021-21043-4.
8
Adoptive T-Cell Therapy for Epstein-Barr Virus-Related Lymphomas.采用过继性T细胞疗法治疗爱泼斯坦-巴尔病毒相关淋巴瘤。
J Clin Oncol. 2021 Feb 10;39(5):514-524. doi: 10.1200/JCO.20.01709. Epub 2021 Jan 12.
9
Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma.抗 PD-1 抗体联合 P-GEMOX 作为晚期自然杀伤/T 细胞淋巴瘤潜在有效的免疫化疗方案。
Signal Transduct Target Ther. 2020 Dec 30;5(1):289. doi: 10.1038/s41392-020-00331-3.
10
Mechanism of EBV inducing anti-tumour immunity and its therapeutic use.EBV 诱导抗肿瘤免疫的机制及其治疗用途。
Nature. 2021 Feb;590(7844):157-162. doi: 10.1038/s41586-020-03075-w. Epub 2020 Dec 23.